Clinical Trials Browser

Phase 2 × quisinostat × Dermatologic × Clear all

NCT06932757 2025-06-03

Adjuvant Quisinostat in High-Risk Uveal Melanoma

Phase 2 Recruiting

Uveal Melanoma

NCT01486277 2016-11-03

A Study of the Histone Deacetylase Inhibitor (HDACi) Quisinostat (JNJ-26481585) in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma

Phase 2 Completed

DermatologicLymphoid

Lymphoma, Lymphoma, T-Cell, Lymphoma, T-Cell, Cutaneous